cancer

Agios helps identify genes that allow cancer to escape the immune system
Agios helps identify genes that allow cancer to escape the immune system
Fierce Biotech
CRISPR
cancer
Agios Pharmaceuticals
immuno-oncology
Flag link:
Report: Illumina in Talks to Acquire Cancer Diagnostics Startup Grail
Report: Illumina in Talks to Acquire Cancer Diagnostics Startup Grail
Motley Fool
M&A
diagnostics
cancer diagnostics
cancer
oncology
Illumina
Grail
Flag link:
Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations
Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations
Biopharma Reporter
Merck
Seattle Genetics
cancer
oncology
ADCs
Tukysa
ladiratuzumab vedotin
Flag link:
Esmo 2020 preview – late-breaking immunotherapy
Esmo 2020 preview – late-breaking immunotherapy
EP Vantage
ESMO
immunotherapy
Big Pharma
Merck
Bristol-Meyers Squibb
cancer
Immunomedics
Roche
Flag link:
Gilead to buy cancer drugmaker Immunomedics for $21B
Gilead to buy cancer drugmaker Immunomedics for $21B
BioPharma Dive
Gilead Sciences
M&A
cancer
Immunomedics
Flag link:
Jazz inks Redx pact to secure 2 targeted cancer therapies
Jazz inks Redx pact to secure 2 targeted cancer therapies
Fierce Biotech
Jazz Pharmaceuticals
Redx
cancer
targeted therapies
Flag link:
Oncology biotech Prelude guns for $100M IPO
Oncology biotech Prelude guns for $100M IPO
Fierce Biotech
Prelude Therapeutics
IPOs
cancer
Flag link:
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
Xconomy
Blueprint Medicines
FDA
Gavreto
pralsetinib
cancer
RET
non-small cell lung cancer
Flag link:
Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy
Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy
MedCity News
Triumvira
Bayer
clinical trials
cell therapy
cancer
Flag link:
Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up
Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up
BioPharma Dive
Foundation Medicine
FDA
cancer
liquid biopsy
diagnostics
solid tumors
pan-cancer
Flag link:
The Inside Story Of Biotech’s Barnum And His Covid Cures
The Inside Story Of Biotech’s Barnum And His Covid Cures
Forbes
Patrick Soon-Shiong
pandemic
cancer
COVID-19
NantKwest
ImmunityBio
Flag link:
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies
Xconomy
Kinnate Biopharma
cancer
oncology
Flag link:
Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Endpoints
Vir Biotechnology
Harbor BioMed
cancer
infectious diseases
Flag link:
'We want to be everywhere.' Mission Bio raises $70M behind resistance-hunting sequencing platform
'We want to be everywhere.' Mission Bio raises $70M behind resistance-hunting sequencing platform
Endpoints
Mission Bio
single cell sequencing
cancer
Flag link:
Achilles Heel of Immunotherapy-Resistant Cancers Revealed – and Eliminated – in Early Studies
Achilles Heel of Immunotherapy-Resistant Cancers Revealed – and Eliminated – in Early Studies
BioSpace
cancer
oncology
immunotherapy-resistant cancer
Flag link:
Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
Fierce Pharma
Sanofi
GSK
FDA
Zantac
DOJ
cancer
product recalls
False Claims Act
Flag link:
Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort
Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort
Fierce Biotech
Eli Lilly
KRAS inhibitors
cancer
Flag link:
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
GSK
R&D
COPD
HIV
cancer
Flag link:
Thrive Brings in $257 Million More to Advance Cancer Liquid Biopsy Assay
Thrive Brings in $257 Million More to Advance Cancer Liquid Biopsy Assay
BioSpace
Thrive Earlier Detection
liquid biopsies
cancer
diagnostics
Flag link:
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
Pharmaforum
AstraZeneca
Daiichi Sankyo
DS-1062
antibodies
cancer
Flag link:

Pages